JAZZ PHARMACEUTICALS Trademark

Trademark Overview

On Friday, June 12, 2015, a trademark application was filed for JAZZ PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the JAZZ PHARMACEUTICALS trademark a serial number of 86661335. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Sunday, April 9, 2023. This trademark is owned by Jazz Pharmaceuticals, Inc.. The JAZZ PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

House mark for a line of pharmaceuticals for the treatment and prevention of cancer, psychiatric diseases and disorders, central nervous system conditions, pain, sleep disorders, narcolepsy, schizophrenia, and for use in oncology and hematology; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations acting on the central nervous system; pain relief medication; pharmaceutical preparations for use in the treatment and/or management of sleep disorders; pharmaceutical preparations for the treatment of narcolepsy; pharmaceutical preparations for the treatment of schizophrenia; pharmaceutical preparations for use in oncology and hematology
jazz pharmaceuticals

General Information

Serial Number86661335
Word MarkJAZZ PHARMACEUTICALS
Filing DateFriday, June 12, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateSunday, April 9, 2023
Registration Number5071067
Registration DateTuesday, November 1, 2016
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 16, 2016

Trademark Statements

Goods and ServicesHouse mark for a line of pharmaceuticals for the treatment and prevention of cancer, psychiatric diseases and disorders, central nervous system conditions, pain, sleep disorders, narcolepsy, schizophrenia, and for use in oncology and hematology; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations acting on the central nervous system; pain relief medication; pharmaceutical preparations for use in the treatment and/or management of sleep disorders; pharmaceutical preparations for the treatment of narcolepsy; pharmaceutical preparations for the treatment of schizophrenia; pharmaceutical preparations for use in oncology and hematology
NOT AVAILABLE"PHARMACEUTICALS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 17, 2015
Primary Code005
First Use Anywhere DateWednesday, September 8, 2004
First Use In Commerce DateWednesday, September 8, 2004

Trademark Owner History

Party NameJazz Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94306
Party NameJazz Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94304
Party NameJazz Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94304

Trademark Events

Event DateEvent Description
Tuesday, June 16, 2015NEW APPLICATION ENTERED
Wednesday, June 17, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 24, 2015ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, September 22, 2015ASSIGNED TO EXAMINER
Monday, September 28, 2015PRIORITY ACTION WRITTEN
Monday, September 28, 2015PRIORITY ACTION E-MAILED
Monday, September 28, 2015NOTIFICATION OF PRIORITY ACTION E-MAILED
Monday, March 28, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 28, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 28, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 29, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 4, 2016FINAL REFUSAL WRITTEN
Monday, April 4, 2016FINAL REFUSAL E-MAILED
Monday, April 4, 2016NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, July 14, 2016EXAMINERS AMENDMENT -WRITTEN
Thursday, July 14, 2016EXAMINERS AMENDMENT E-MAILED
Thursday, July 14, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, July 14, 2016EXAMINER'S AMENDMENT ENTERED
Thursday, July 14, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 27, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 16, 2016PUBLISHED FOR OPPOSITION
Tuesday, August 16, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 1, 2016REGISTERED-PRINCIPAL REGISTER
Friday, March 23, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 23, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, June 15, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, June 15, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 26, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, November 1, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, September 29, 2022TEAS SECTION 8 & 15 RECEIVED
Sunday, April 9, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sunday, April 9, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sunday, April 9, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, November 1, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, November 11, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 11, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 11, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 11, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 11, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

pharmaceuticals jazz pharmaceutical treatment preparations disorders pain sleep schizophrenia hematology oncology system